Preimplantation genetic diagnosis (PGD) is the screening of individual embryos for genetic disorders or gender determination during the IVF process. At ART Reproductive Center, part of SCRC, the PGD procedure is a primary focus, and director Dr. David Hill is a nationally recognized expert in its use.
The preimplantation genetic diagnosis (PGD) procedure allows the screening of embryos for specific genetic traits before an embryo is implanted in a patient’s uterus. Also known as “embryo biopsy,” PGD enables couples at risk for certain genetic diseases to determine which of their embryos are affected, and which are not, before the embryos are used to establish a pregnancy.
We use PGD at the Southern California Reproductive Center to detect abnormalities in chromosomes, hereditary conditions, and for gender selection.
PGD can increase the chance of pregnancy because the pre-screening process identifies poor-quality embryos that are unlikely to survive implantation and a normal pregnancy. This also leads to a significant reduction in the chance of miscarriage. PGD can reduce the risk of multiple pregnancy because fewer embryos are needed for implantation. In addition, the patients who can benefit from PGD include:
Family balancing is one of several issues that can arise with the concept of gender determination. Our SCRC physicians will be glad to discuss the options available to couples that include determination of gender of their pre-embryos as part of the preimplantation genetic screening panel.
PGD requires patients to undergo an in vitro fertilization (IVF) cycle in order to produce pre-embryos available for testing.
Before the transfer of a pre-embryo back to a woman’s uterus, some cells (called blastomeres) are removed from the available pre-embryos. These blastomeres are evaluated for abnormalities. Following completion of the evaluation (typically one to two days), only the normal pre-embryos are transferred back to the woman’s uterus to establish a pregnancy.
PGD can be used for determining chromosomal health (with PGD-FISH or PGD-CGH) or the presence or absence of specific genes related to hereditary disease (with PGD-PCR).
The most common chromosomal abnormalities occur when there is an incorrect number of chromosomes, a condition known as aneuploidy. Some chromosomes are more likely than others to become unpaired, which can lead to early embryonic demise (chromosomes 13, 16, 18, and 22) or affect term births, such as Down syndrome (trisomy 21). Numerical mistakes in the sex chromosomes can lead to Turner’s syndrome (XO), or Klinefelter’s syndrome (XXY). Sometimes, chromosomes can break apart and attach to other chromosomes, a condition known as translocation. Translocations have been associated with miscarriage as well as many serious diseases, including some forms of leukemia. Checking for normal chromosome pairing is done using a technique called fluorescent in situ hybridization (FISH), an established component of the preimplantation genetic diagnosis (PGD) testing at our clinics.
PGD-CGH is a recent advance in the screening of pre-embryos for chromosomal normality. Its primary advantage is that CGH looks at all 23 pairs of chromosomes instead of a maximum of 12 pairs using PGD-FISH. PGD-CGH may require the cryopreservation of embryos while their cells are being tested; normal embryos are identified, thawed and transferred to the patient typically at her next ovulation cycle.
The method of analysis for gene disorders is called polymerase chain reaction (PCR). PCR involves a technique that greatly amplifies the genetic code contained in a single blastomere, so that the specific gene or genes being looked for can be detected. Preimplantation genetic diagnosis is significantly enhanced by the use of PCR. Examples of hereditary conditions caused by gene disorders that PCR can help detect include:
Until the development of PGD, assisted reproductive technology labs could rely only on the appearance of pre-embryos to decide which ones were suitable for implantation into the patient’s uterus. The advent of PGD proved that normal-appearing pre-embryos frequently have an abnormal number of chromosomes, rendering them incompatible with the development of a normal pregnancy.
Indeed, the use of PGD by the fertility specialists at the Southern California Reproductive Center has been instrumental in bringing many babies into the world.
While manipulating and handling embryos will always have some measure of risk, it is important to note that our center has the most extensive experience of any in the USA. The real risk is in NOT using PGD, and then having a miscarriage or carrying a child to term with a serious genetic disorder that could have been detected through PGD testing.
The cost of PGD depends on the specific types of tests desired or requested (see above for the variety of genetic tests that comprise the PGD process). At SCRC, we are able to offer you several different financing plans to make the cost manageable and affordable. Please talk to one of our staff members for details.
In 1999, the genetic code of an entire human chromosome was sequenced (mapped). This revolutionary development in medical science allowed the continuing discovery of the sequence of the code that comprises specific units of genetic information. Genes are responsible for directing the construction of every cell in our body, down to the tiniest molecular detail. Therefore, it is reasonable to expect that the function of all genes, and the detection of abnormal genes, eventually will be categorized. This knowledge may in turn be used to reduce or eliminate susceptibility to hereditary disorders, infectious diseases, and cancer. Someday, only asingle pre-embryo will be needed to establish a pregnancy — and it will be a healthy pregnancy.